Literature DB >> 1639855

Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.

G R Johnson1, T Saeki, A W Gordon, M Shoyab, D S Salomon, K Stromberg.   

Abstract

Amphiregulin (AR) is a newly discovered glycosylated, 84-amino acid residue polypeptide growth regulator which has sequence homology to the EGF family of proteins. To obtain immunological reagents to study the biological role of AR, two synthetic peptides containing sequences corresponding to distinct regions of AR were used to generate polyclonal antibodies in rabbits. One preparation of antipeptide antibodies directed against residues 26-44 of AR (AR-Ab2) was most effective in the detection of native AR, whereas another preparation of antibodies against residues 8-26 (AR-Ab1) was found to be most efficacious in the detection of AR in formalin-fixed and paraffin-embedded tissues. The growth of a colon carcinoma cell line, Geo, which proliferates autonomously under serum-free conditions, was stimulated by the exogenous addition of AR or EGF. Half-maximal stimulation of this growth was observed at 40 and 200 pM of EGF and AR, respectively. A mAb to the extracellular domain of the EGF receptor blocked the stimulation of cell proliferation induced by the exogenous addition of AR, suggesting that this stimulation was mediated via the EGF receptor. Geo cells were found to constitutively express significant levels of the AR mRNA transcript as determined by analysis of the polymerase chain reaction-amplified cDNA product and AR protein was detected immunocytochemically using the AR-Ab1 antibodies in these cells. AR was immunoprecipitated specifically using the AR-Ab2 antibodies from the conditioned medium of Geo cells, which had been metabolically labeled with [35S]cysteine. The secreted AR migrated as a broad band (18.5-22.5 kD) with a median molecular weight of approximately 20.7 kD in SDS-PAGE. Immunospecific removal of AR from serum-free medium conditioned by the Geo cells and readdition of the AR-depleted medium to Geo cells resulted in an approximately 40% inhibition of cell growth relative to controls. Furthermore, the growth of the Geo cells was also inhibited by approximately 50% by the addition of the anti-EGF receptor mAb alone. These results indicate that AR and the EGF receptor are involved in the autocrine growth of these cells and suggests that AR may act through the EGF receptor via an extracellular autocrine loop. To study the expression of AR in human colon in vivo, AR was localized immunocytochemically in formalin-fixed, paraffin-embedded sections from normal and malignant human colon using the AR-Ab1 antibodies.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639855      PMCID: PMC2289555          DOI: 10.1083/jcb.118.3.741

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  39 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

Authors:  H D Soule; T M Maloney; S R Wolman; W D Peterson; R Brenz; C M McGrath; J Russo; R J Pauley; R F Jones; S C Brooks
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

3.  Epidermal growth factor receptors in colorectal carcinoma.

Authors:  M Moorghen; P Ince; K J Finney; A J Watson; A L Harris
Journal:  Anticancer Res       Date:  1990 May-Jun       Impact factor: 2.480

4.  Novel method for studying mRNA phenotypes in single or small numbers of cells.

Authors:  D A Rappolee; A Wang; D Mark; Z Werb
Journal:  J Cell Biochem       Date:  1989-01       Impact factor: 4.429

5.  Structure and function of human amphiregulin: a member of the epidermal growth factor family.

Authors:  M Shoyab; G D Plowman; V L McDonald; J G Bradley; G J Todaro
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

Review 6.  Autocrine growth factors and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

7.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.

Authors:  D A Rappolee; D Mark; M J Banda; Z Werb
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

8.  Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines.

Authors:  C W Wan; M K McKnight; D E Brattain; M G Brattain; L C Yeoman
Journal:  Cancer Lett       Date:  1988-12-01       Impact factor: 8.679

9.  Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0----G1 transition.

Authors:  G Bouche; N Gas; H Prats; V Baldin; J P Tauber; J Teissié; F Amalric
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract.

Authors:  L T Malden; U Novak; A W Burgess
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

View more
  33 in total

1.  HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.

Authors:  David Liska; Chin-Tung Chen; Thomas Bachleitner-Hofmann; James G Christensen; Martin R Weiser
Journal:  Clin Cancer Res       Date:  2010-11-22       Impact factor: 12.531

2.  Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa.

Authors:  S Abe; H Sasano; K Katoh; S Ohara; T Arikawa; T Noguchi; S Asaki; W Yasui; E Tahara; H Nagura; T Toyota
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Topography of amphiregulin expression in cultured human keratinocytes: colocalization with the epidermal growth factor receptor and CD44.

Authors:  N Nylander; L T Smith; R A Underwood; M Piepkorn
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

4.  Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).

Authors:  Brittany L Carpenter; Min Chen; Teresa Knifley; Kelley A Davis; Susan M W Harrison; Rachel L Stewart; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

5.  Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.

Authors:  T Oikawa; J Hitomi; A Kono; E Kaneko; K Yamaguchi
Journal:  Int J Pancreatol       Date:  1995-08

6.  Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells.

Authors:  C D Woodworth; E McMullin; M Iglesias; G D Plowman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis.

Authors:  Hideji Nakamura; Kenya Yoshida; Kazuhiro Ikegame; Yoshihiko Kishima; Hirokazu Uyama; Hirayuki Enomoto
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

8.  Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers.

Authors:  Kimio Yonesaka; Kreshnik Zejnullahu; Neal Lindeman; Alison J Homes; David M Jackman; Feng Zhao; Andrew M Rogers; Bruce E Johnson; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

9.  TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.

Authors:  Nipun B Merchant; Igor Voskresensky; Christopher M Rogers; Bonnie Lafleur; Peter J Dempsey; Ramona Graves-Deal; Frank Revetta; A Coe Foutch; Mace L Rothenberg; Mary K Washington; Robert J Coffey
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

10.  Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.

Authors:  Glen A Doherty; Sinead M Byrne; Eamonn S Molloy; Vikrum Malhotra; Sandra C Austin; Elaine W Kay; Frank E Murray; Desmond J Fitzgerald
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.